What We Do

Phraxis, Inc. is an early-stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first planned product for commercialization, the InterGraft Vascular Anastomotic Connector, is a transcatheter-delivered venous anastomotic connector that provides a unique, minimally invasive approach for patients who need vascular access.   

Phraxis is developing devices to facilitate placement of AV grafts for vascular access using standard interventional techniques to enable physicians to effectively manage dialysis patients.

The executive management group of Phraxis, Inc has extensive experience in general management, product development, clinical and regulatory affairs, and startup to commercialization experience in medical device companies (MJK), as well as clinical experience in interventional nephrology (ASY).